The androgen receptor's CAG/glutamine tract in mouse models of neurological disease and cancer

Journal of Alzheimer's Disease

Volumn 14, Issue 2, 2008, Pages 247-255

  Lieberman, Andrew P ^a   Robins, Diane M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Androgen receptor; CAG polyglutamine; Kennedy disease; Mouse models; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; GLUTAMINE;

ALLELE; AR GENE; CANCER GROWTH; DISTAL MYOPATHY; GENE; GENE INSERTION; GENE TARGETING; GENETIC CODE; GENETIC VARIABILITY; HISTOPATHOLOGY; KENNEDY DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; REVIEW;

EID: 47849086388     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-14212     Document Type: Review

References (59)

1. A. Abdullah, M.A. Trifiro, V. Panet-Raymond, C. Alvarado, S. de Tourreil, D. Frankel, H.M. Schipper and L. Pinsky, Spinobulbar muscular atrophy: polyglutamine-expanded androgen receptor is proteolytically resistant in vitro and processed abnormally in transfected cells, Hum Mol Genet 7 (1998), 379-384.
2. A. Abel, J. Walcott, J. Woods, J. Duda and D.E. Merry, Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice, Hum Mol Genet 10 (2001), 107-116.
3. H. Adachi, A. Kume, M. Li, Y. Nakagomi, H. Niwa, J. Do, C. Sang, Y. Kobayashi, M. Doyu and G. Sobue, Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death, Hum Mol Genet 10 (2001), 1039-1048.
4. M.A. Albertelli, A. Scheller, M. Brogley and D.M. Robins, Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice, Mol Endocrinol 20 (2006), 1248-1260.
5. M.A. Albertelli, A. O'Mahony, M. Brogley, J. Tosoian, M. Steinkamp, S. Daignault, K. Wojno and D.M. Robins, Glutamine Tract Length of Human Androgen Receptors Affects Hormone-Dependent and -Independent Prostate Cancer in Mice, Hum Mol Genet (2007), epub ahead of print.
6. T. Arbizu, J. Santamaria, J.M. Gomez, A. Quilez and J.P. Serra, A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure, J Neurol Sci 59 (1983), 371-382.
7. H. Banno, H. Adachi, M. Katsuno, K. Suzuki, N. Atsuta, H. Watanabe, F.Tanaka, M.Doyu and G. Sobue, Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker, Ann Neurol 59 (2006), 520-526.
8. M.W. Becher, J.A. Kotzuk, A.H. Sharp, S.W. Davies, G.P. Bates, D.L. Price and C.A. Ross, Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length, Neurobiol Dis 4 (1998), 387-397.
9. G. Buchanan, M. Yang, A. Cheong, J.M. Harris, R.A. Irvine, P.F. Lambert, N.L. Moore, M. Raynor, P.J. Neufing, G.A. Coetzee andW.D. Tilley, Structural and functional consequences of glutamine tract variation in the androgen receptor, Hum Mol Genet 13 (2004), 1677-1692.
10. N.L. Chamberlain, E.D. Driver and R.L. Miesfeld, The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function, Nucleic Acids Res 22 (1994), 3181-3186.
11. E.S. Chevalier-Larsen, C.J. O'Brien, H. Wang, S.C. Jenkins, L. Holder, A.P. Lieberman and D.E. Merry, Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy, J Neurosci 24 (2004), 4778-4786.
12. G. David, A. Durr, G. Stevanin, G. Cancel, N. Abbas, A. Benomar, S. Belal, A.S. Lebre, M. Abada-Bendib, D. Grid, M. Holmberg, M. Yahyaoui, F. Hentati, T. Chkili, Y. Agid and A. Brice, Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7), Hum Mol Genet 7 (1998), 165-170.
13. S.W. Davies, M. Turmaine, B.A. Cozens, M. DiFiglia, A.H. Sharp, C.A. Ross, E. Scherzinger, E.E.Wanker, L. Mangiarini and G.P. Bates, Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation, Cell 90 (1997), 537-548.
14. K.H. Fischbeck, A. Lieberman, C.K. Bailey, A. Abel and D.E. Merry, Androgen receptor mutation in Kennedy's disease, Philos Trans R Soc Lond B Biol Sci 354 (1999), 1075-1078.
15. L.R. Fischer and J.D. Glass, Axonal degeneration in motor neuron disease, Neurodegener Dis 4 (2007), 431-442.
16. M.L. Freedman, C.L. Pearce, K.L. Penney, J.N. Hirschhorn, L.N. Kolonel, B.E. Henderson and D. Altshuler, Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study, Am J Hum Genet 76 (2005), 82-90.
17. E. Giovannucci, Is the androgen receptor CAG repeat length significant for prostate cancer? Cancer Epidemiol Biomarkers Prev 11 (2002), 985-986.
18. B. Gottlieb, L.K. Beitel, J.H.Wu and M. Trifiro, The androgen receptor gene mutations database (ARDB): 2004 update, Hum Mutat 23 (2004), 527-533.
19. N.M. Greenberg, F. DeMayo, M.J. Finegold, D. Medina,W.D. Tilley, J.O. Aspinall, G.R. Cunha, A.A. Donjacour, R.J. Matusik and J.M. Rosen, Prostate cancer in a transgenic mouse, Proc Natl Acad Sci U S A 92 (1995), 3439-3443.
20. P.W. Hsiao, D.L. Lin, R. Nakao and C. Chang, The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator, J Biol Chem 274 (1999), 20229-20234.
21. R.A. Irvine, M.C. Yu, R.K. Ross, and G.A. Coetzee, The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer, Cancer Res 55 (1995), 1937-1940.
22. M. Katsuno, H. Adachi, A. Kume, M. Li, Y. Nakagomi, H. Niwa, C. Sang, Y. Kobayashi, M. Doyu and G. Sobue, Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy, Neuron 35 (2002), 843-854.
23. M. Katsuno, H. Adachi, M. Waza, H. Banno, K. Suzuki, F. Tanaka, M. Doyu, and G. Sobue, Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA), Exp Neurol 200 (2006), 8-18.
24. P. Kazemi-Esfarjani, M.A. Trifiro and L. Pinsky, Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies, Hum Mol Genet 4 (1995), 523-527.
25. W.R. Kennedy, M. Alter and J.H. Sung, Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait, Neurology 18 (1968), 671-680.
26. R. Klocke, K. Steinmeyer, T.J. Jentsch and H. Jockusch, Role of innervation, excitability, and myogenic factors in the expression of the muscular chloride channel ClC-1. A study on normal and myotonic muscle, J Biol Chem 269 (1994), 27635-27639.
27. T.Y. Kostrominova, D.E. Dow, R.G. Dennis, R.A. Miller and J.A. Faulkner, Comparison of gene expression of 2-mo denervated, 2-mo stimulated-denervated, and control rat skeletal muscles, Physiol Genomics 22 (2005), 227-243.
28. K.A.Kujawa, E. Emeric and K.J. Jones, Testosterone differentially regulates the regenerative properties of injured hamster facial motoneurons, J Neurosci 11 (1991), 3898-3906.
29. E.M. Kurz, D.R. Sengelaub and A.P. Arnold, Androgens regulate the dendritic length of mammalian motoneurons in adulthood, Science 232 (1986), 395-398.
30. A.R. La Spada, E.M. Wilson, D.B. Lubahn, A.E. Harding and K.H. Fischbeck, Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy, Nature 352 (1991), 77-79.
31. A.R. La Spada, D.B. Roling, A.E. Harding, C.L. Warner, R. Spiegel, I. Hausmanowa-Petrusewicz, W.C. Yee and K.H. Fischbeck, Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy, Nat Genet 2 (1992), 301-304.
32. B.R. Leavitt, J.A. Guttman, J.G. Hodgson, G.H. Kimel, R. Singaraja, A.W. Vogl and M.R. Hayden, Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo, Am J Hum Genet 68 (2001), 313-324.
33. M. Li, E.S. Chevalier-Larsen, D.E. Merry and M.I. Diamond, Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy, J Biol Chem 282 (2007), 3157-3164.
34. A.P. Lieberman, Y. Robitaille, J.Q. Trojanowski, D.W. Dickson and K.H. Fischbeck, Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease, Lancet 351 (1998), 884.
35. A.P. Lieberman, J.Q. Trojanowski, D.G. Leonard, K.L. Chen, J.L. Barnett, J.B. Leverenz, T.D. Bird, Y. Robitaille, A. Malandrini and K.H. Fischbeck, Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease, Ann Neurol 46 (1999), 271-273.
36. A.P. Lieberman, G. Harmison, A.D. Strand, J.M. Olson and K.H. Fischbeck, Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor, Hum Mol Genet 11 (2002), 1967-1976.
37. C. Mauger, J. Del-Favero, C. Ceuterick, U. Lubke, C. van Broeckhoven and J. Martin, Identification and localization of ataxin-7 in brain and retina of a patient with cerebellar ataxia type II using anti-peptide antibody, Brain Res Mol Brain Res 74 (1999), 35-43.
38. P. McManamny, H.S. Chy, D.I. Finkelstein, R.G. Craythorn, P.J. Crack, I. Kola, S.S. Cheema, M.K. Horne, N.G. Wreford, M.K. O'Bryan, D.M. De Kretser and J.R. Morrison, A mouse model of spinal and bulbar muscular atrophy, Hum Mol Genet 11 (2002), 2103-2111.
39. A. Mejat, F. Ramond, R. Bassel-Duby, S. Khochbin, E.N. Olson and L. Schaeffer, Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression, Nat Neurosci 8 (2005), 313-321.
40. D.E. Merry, Y. Kobayashi, C.K. Bailey, A.A. Taye and K.H. Fischbeck, Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy, Hum Mol Genet 7 (1998), 693-701.
41. A.N. Mhatre, M.A. Trifiro, M. Kaufman, P. Kazemi-Esfarjani, D. Figlewicz, G. Rouleau and L. Pinsky, Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy, Nat Genet 5 (1993), 184-188.
42. D.A. Monks, J.A. Johansen, K. Mo, P. Rao, B. Eagleson, Z. Yu, A.P. Lieberman, S.M. Breedlove and C.L. Jordan, Over-expression of wild-type androgen receptor in muscle recapitulates polyglutamine disease, Proc Natl Acad Sci U S A 104 (2007), 18259-18264.
43. T. Nagashima, K. Seko, K. Hirose, T. Mannen, S. Yoshimura, R. Arima, K. Nagashima and Y. Morimatsu, Familial bulbospinal muscular atrophy associated with testicular atrophy and sensory neuropathy (Kennedy-Alter-Sung syndrome). Autopsy case report of two brothers, J Neurol Sci 87 (1988), 141-152.
44. E.J. Nordeen, K.W. Nordeen, D.R. Sengelaub and A.P. Arnold, Androgens prevent normally occurring cell death in a sexually dimorphic spinal nucleus, Science 229 (1985), 671-673.
45. H.T. Orr and H.Y. Zoghbi, Trinucleotide repeat disorders, Annu Rev Neurosci 30 (2007), 575-621.
46. H.L. Paulson, M.K. Perez, Y. Trottier, J.Q. Trojanowski, S.H. Subramony, S.S. Das, P. Vig, J.L. Mandel, K.H. Fischbeck and R.N. Pittman, Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3, Neuron 19 (1997), 333-344.
47. A.K. Roy, R.K. Tyagi, C.S. Song, Y. Lavrovsky, S.C. Ahn, T.S. Oh and B. Chatterjee, Androgen receptor: structural domains and functional dynamics after ligand-receptor interaction, Ann N Y Acad Sci 949 (2001), 44-57.
48. B.J. Schmidt, C.R. Greenberg, D.J. Allingham-Hawkins and E.L. Spriggs, Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women, Neurology 59 (2002), 770-772.
49. H.C. Shen and G.A. Coetzee, The androgen receptor: unlocking the secrets of its unique transactivation domain, Vitam Horm 71 (2005), 301-319.
50. P.J. Skinner, B.T. Koshy, C.J. Cummings, I.A. Klement, K. Helin, A. Servadio, H.Y. Zoghbi and H.T. Orr, Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures, Nature 389 (1997), 971-974.
51. G. Sobue, Y. Hashizume, E. Mukai, M. Hirayama, T. Mitsuma and A. Takahashi, X-linked recessive bulbospinal neuronopathy. A clinicopathological study, Brain 112(Pt 1) (1989), 209-232.
52. G. Sobue, M. Doyu, T. Kachi, T. Yasuda, E. Mukai, T. Kumagai and T. Mitsuma, Subclinical phenotypic expressions in heterozygous females of X-linked recessive bulbospinal neuronopathy, J Neurol Sci 117 (1993), 74-78.
53. B.L. Sopher, P.S. Thomas, Jr., M.A. LaFevre-Bernt, I.E. Holm, S.A.Wilke, C.B.Ware, L.W. Jin, R.T. Libby, L.M. Ellerby and A.R. La Spada, Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration, Neuron 41 (2004), 687-699.
54. Q. Wang, T.S. Udayakumar, T.S. Vasaitis, A.M. Brodie and J.D. Fondell, Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells, J Biol Chem 279 (2004), 17319-17328.
55. W.H. Yu, Administration of testosterone attenuates neuronal loss following axotomy in the brain-stem motor nuclei of female rats, J Neurosci 9 (1989), 3908-3914.
56. Z. Yu, N. Dadgar, M. Albertelli, K. Gruis, C. Jordan, D.M. Robins and A.P. Lieberman, Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model, J Clin Invest 116 (2006), 2663-2672.
57. Z. Yu, N. Dadgar, M. Albertelli, A. Scheller, R.L. Albin, D.M. Robins and A.P. Lieberman, Abnormalities of Germ Cell Maturation and Sertoli Cell Cytoskeleton in Androgen Receptor 113 CAG Knock-In Mice Reveal Toxic Effects of the Mutant Protein, Am J Pathol 168 (2006), 195-204.
58. M. Zitzmann and E. Nieschlag, The CAG repeat polymorphism within the androgen receptor gene and maleness, Int J Androl 26 (2003), 76-83.
59. H.Y. Zoghbi and H.T. Orr, Glutamine repeats and neurodegeneration, Annu Rev Neurosci 23 (2000), 217-247.